Logo image of KSCP

KNIGHTSCOPE INC-A (KSCP) Stock Fundamental Analysis

NASDAQ:KSCP - Nasdaq - US49907V2016 - Common Stock - Currency: USD

8.02  -0.46 (-5.42%)

After market: 8.3 +0.28 (+3.49%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to KSCP. KSCP was compared to 84 industry peers in the Commercial Services & Supplies industry. Both the profitability and financial health of KSCP have multiple concerns. KSCP is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

In the past year KSCP has reported negative net income.
In the past year KSCP has reported a negative cash flow from operations.
In the past 5 years KSCP always reported negative net income.
KSCP had a negative operating cash flow in each of the past 5 years.
KSCP Yearly Net Income VS EBIT VS OCF VS FCFKSCP Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 -10M -20M -30M -40M

1.2 Ratios

Looking at the Return On Assets, with a value of -117.06%, KSCP is doing worse than 96.34% of the companies in the same industry.
The Return On Equity of KSCP (-257.15%) is worse than 90.24% of its industry peers.
Industry RankSector Rank
ROA -117.06%
ROE -257.15%
ROIC N/A
ROA(3y)-155.08%
ROA(5y)-153.84%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
KSCP Yearly ROA, ROE, ROICKSCP Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 0 500 1K 1.5K

1.3 Margins

KSCP does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
KSCP Yearly Profit, Operating, Gross MarginsKSCP Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 -200 -400 -600 -800 -1K

3

2. Health

2.1 Basic Checks

KSCP does not have a ROIC to compare to the WACC, probably because it is not profitable.
KSCP has less shares outstanding than it did 1 year ago.
KSCP has less shares outstanding than it did 5 years ago.
The debt/assets ratio for KSCP has been reduced compared to a year ago.
KSCP Yearly Shares OutstandingKSCP Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M
KSCP Yearly Total Debt VS Total AssetsKSCP Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M

2.2 Solvency

KSCP has an Altman-Z score of -11.65. This is a bad value and indicates that KSCP is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -11.65, KSCP is doing worse than 93.90% of the companies in the same industry.
KSCP has a Debt/Equity ratio of 0.38. This is a healthy value indicating a solid balance between debt and equity.
KSCP has a Debt to Equity ratio (0.38) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF N/A
Altman-Z -11.65
ROIC/WACCN/A
WACC8.4%
KSCP Yearly LT Debt VS Equity VS FCFKSCP Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 0 10M -10M -20M

2.3 Liquidity

KSCP has a Current Ratio of 1.21. This is a normal value and indicates that KSCP is financially healthy and should not expect problems in meeting its short term obligations.
KSCP's Current ratio of 1.21 is on the low side compared to the rest of the industry. KSCP is outperformed by 68.29% of its industry peers.
A Quick Ratio of 0.84 indicates that KSCP may have some problems paying its short term obligations.
KSCP's Quick ratio of 0.84 is on the low side compared to the rest of the industry. KSCP is outperformed by 78.05% of its industry peers.
Industry RankSector Rank
Current Ratio 1.21
Quick Ratio 0.84
KSCP Yearly Current Assets VS Current LiabilitesKSCP Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M 10M

5

3. Growth

3.1 Past

The earnings per share for KSCP have decreased strongly by -1688.17% in the last year.
The Revenue has grown by 16.66% in the past year. This is quite good.
KSCP shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 34.20% yearly.
EPS 1Y (TTM)-1688.17%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%37.5%
Revenue 1Y (TTM)16.66%
Revenue growth 3Y56.63%
Revenue growth 5Y34.2%
Sales Q2Q%-10.1%

3.2 Future

Based on estimates for the next years, KSCP will show a quite strong growth in Earnings Per Share. The EPS will grow by 17.73% on average per year.
KSCP is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 13.10% yearly.
EPS Next Y26.59%
EPS Next 2Y24.6%
EPS Next 3Y17.73%
EPS Next 5YN/A
Revenue Next Year-16.35%
Revenue Next 2Y0.61%
Revenue Next 3Y13.1%
Revenue Next 5YN/A

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
KSCP Yearly Revenue VS EstimatesKSCP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 5M 10M 15M
KSCP Yearly EPS VS EstimatesKSCP Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 -5 -10 -15

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for KSCP. In the last year negative earnings were reported.
Also next year KSCP is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
KSCP Price Earnings VS Forward Price EarningsKSCP Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
KSCP Per share dataKSCP EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -5 -10 -15

4.3 Compensation for Growth

KSCP's earnings are expected to grow with 17.73% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y24.6%
EPS Next 3Y17.73%

0

5. Dividend

5.1 Amount

KSCP does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

KNIGHTSCOPE INC-A

NASDAQ:KSCP (2/21/2025, 8:00:02 PM)

After market: 8.3 +0.28 (+3.49%)

8.02

-0.46 (-5.42%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)11-14 2024-11-14/amc
Earnings (Next)N/A N/A
Inst Owners14.43%
Inst Owner Change70.29%
Ins Owners0.56%
Ins Owner Change0%
Market Cap33.76M
Analysts82.86
Price Target22.1 (175.56%)
Short Float %15.96%
Short Ratio2.67
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-14.38%
Min EPS beat(2)-30.72%
Max EPS beat(2)1.96%
EPS beat(4)1
Avg EPS beat(4)-15.74%
Min EPS beat(4)-30.72%
Max EPS beat(4)1.96%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)11.99%
Min Revenue beat(2)-33.04%
Max Revenue beat(2)57.01%
Revenue beat(4)3
Avg Revenue beat(4)8.62%
Min Revenue beat(4)-33.04%
Max Revenue beat(4)57.01%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)-6.77%
EPS NY rev (3m)-6.77%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)-11.47%
Revenue NY rev (3m)-11.47%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.86
P/FCF N/A
P/OCF N/A
P/B 3.02
P/tB 4.3
EV/EBITDA N/A
EPS(TTM)-15.5
EYN/A
EPS(NY)-7.3
Fwd EYN/A
FCF(TTM)-6.08
FCFYN/A
OCF(TTM)-6.08
OCFYN/A
SpS2.8
BVpS2.65
TBVpS1.87
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -117.06%
ROE -257.15%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-155.08%
ROA(5y)-153.84%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.48
Health
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 0.04%
Cap/Sales 0.01%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.21
Quick Ratio 0.84
Altman-Z -11.65
F-Score2
WACC8.4%
ROIC/WACCN/A
Cap/Depr(3y)11.17%
Cap/Depr(5y)6.98%
Cap/Sales(3y)3.01%
Cap/Sales(5y)1.94%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1688.17%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%37.5%
EPS Next Y26.59%
EPS Next 2Y24.6%
EPS Next 3Y17.73%
EPS Next 5YN/A
Revenue 1Y (TTM)16.66%
Revenue growth 3Y56.63%
Revenue growth 5Y34.2%
Sales Q2Q%-10.1%
Revenue Next Year-16.35%
Revenue Next 2Y0.61%
Revenue Next 3Y13.1%
Revenue Next 5YN/A
EBIT growth 1Y1.42%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-9.9%
EBIT Next 3Y-0.06%
EBIT Next 5YN/A
FCF growth 1Y-9.21%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-10.1%
OCF growth 3YN/A
OCF growth 5YN/A